Trials / Sponsors / Inmunova S.A.
Inmunova S.A.
Academic / Other · 6 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Efficacy of INM004 in Children With STEC-HUS Hemolytic-Uremic Syndrome | Phase 3 | 2024-10-05 |
| Completed | A Study to Assess Safety, Efficacy, and Pharmacokinetics of INM004 in Pediatric Patients With STEC-HUS Diarrhea-Associated Hemolytic Uremic Syndrome, Pediatric Kidney Disease, Hemolytic-Uremic Syndrome | Phase 2 | 2022-10-06 |
| Completed | Effectiveness and Safety Study of Specific Hyperimmune Equine Serum for the Treatment of Severe Hospitalized S Covid19 | — | 2021-05-22 |
| Completed | A Study to Investigate the Pharmacokinetics, Efficacy and Safety of INM005 in Patients With COVID-19. Covid19 | Phase 2 / Phase 3 | 2020-07-27 |
| Terminated | Phase 2/3 Study to Evaluate PK, Safety & Efficacy of INM004 in STEC Positive Pediatric Patients for Prevention Bloody Diarrhea, STEC, Unspecified, Hemolytic-Uremic Syndrome | Phase 2 / Phase 3 | 2019-07-17 |
| Completed | Anti-Shiga Toxin Hyperimmune Equine Immunoglobulin F(ab')2 Fragment (INM004) in Healthy Volunteers Healthy Volunteers | Phase 1 | 2017-12-16 |